Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-005048

Chief Medical Officer gave up 4,678 shares (to pay taxes)

  • Chief Medical Officer acquired 11,248 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-01-17 Option exercise +11,248 32,796 D: show line 1 in the form
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-01-17 Shares withheld for taxes −4,678 $6.43 $30,080 28,118 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-01-17 Option exercise · Restricted Stock Units −11,248 22,502 D: show line 3 in the form
Loading xslF345X03/tm233853d3_4seq1.xml…